Testing effectiveness (Phase 2)Looking for participantsNCT06838962
What this trial is testing
Anti-CD38 Antibody Treating Children With Primary Immune Thrombocytopenia (ITP)
Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 30